AAAAAA

   
Results: 1-8 |
Results: 8
RELIABILITY OF USING RESULTS OF ABDOMINAL FLUID ANALYSIS TO DETERMINETREATMENT AND PREDICT LESION TYPE AND OUTCOME FOR HORSES WITH COLIC -218 CASES (1991-1994)
Authors: FREDEN GO PROVOST PJ RAND WM
Citation: Go. Freden et al., RELIABILITY OF USING RESULTS OF ABDOMINAL FLUID ANALYSIS TO DETERMINETREATMENT AND PREDICT LESION TYPE AND OUTCOME FOR HORSES WITH COLIC -218 CASES (1991-1994), Journal of the American Veterinary Medical Association, 213(7), 1998, pp. 1012
IMMUNOPRECIPITATION AND VIRUS NEUTRALIZATION ASSAYS DEMONSTRATE QUALITATIVE DIFFERENCES BETWEEN PROTECTIVE ANTIBODY-RESPONSES TO INACTIVATED HEPATITIS-A VACCINE AND PASSIVE-IMMUNIZATION WITH IMMUNE GLOBULIN
Authors: LEMON SM MURPHY PC PROVOST PJ CHALIKONDA I DAVIDE JP SCHOFIELD TL NALIN DR LEWIS JA
Citation: Sm. Lemon et al., IMMUNOPRECIPITATION AND VIRUS NEUTRALIZATION ASSAYS DEMONSTRATE QUALITATIVE DIFFERENCES BETWEEN PROTECTIVE ANTIBODY-RESPONSES TO INACTIVATED HEPATITIS-A VACCINE AND PASSIVE-IMMUNIZATION WITH IMMUNE GLOBULIN, The Journal of infectious diseases, 176(1), 1997, pp. 9-19
SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 2 REGIMENS OF OKA MERCK VARICELLA VACCINE (VARIVAX(R)) IN HEALTHY ADOLESCENTS AND ADULTS/
Authors: KUTER BJ NGAI A PATTERSON CM STAEHLE BO CHO IS MATTHEWS H PROVOST PJ WHITE CJ ARVIN A ARBETER A BALFOUR H BLUMBERG D BRUNELL P CHARTRAND S CHERRY J CLEMENTS D DAVIDSON M DEMMLER G DENNEHY P GERSHON A HARRIS A HAYDEN F JACOBSON J KESSLER H KUMAR M LAW B LEVIN M MAURER H OXMAN M REISINGER K SNYDMAN D SAVOIA M STARR S WHITLEY R WONG V YOGEV R
Citation: Bj. Kuter et al., SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 2 REGIMENS OF OKA MERCK VARICELLA VACCINE (VARIVAX(R)) IN HEALTHY ADOLESCENTS AND ADULTS/, Vaccine, 13(11), 1995, pp. 967-972
HISTOLOGIC AND ULTRASTRUCTURAL-CHANGES AF TER LARGE-COLON TORSION, WITH AND WITHOUT USE OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST(WEB 2086), IN PONIES
Authors: WILSON DV PATTERSON JS STICK JA PROVOST PJ
Citation: Dv. Wilson et al., HISTOLOGIC AND ULTRASTRUCTURAL-CHANGES AF TER LARGE-COLON TORSION, WITH AND WITHOUT USE OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST(WEB 2086), IN PONIES, Pferdeheilkunde, 11(1), 1995, pp. 71-71
COMBINED USE OF COMPLEMENT AND ANTIIMMUNOGLOBULIN IN AN ENHANCED NEUTRALIZATION ASSAY FOR ANTIBODIES TO VARICELLA-ZOSTER VIRUS
Authors: KRAH DL PROVOST PJ ELLIS RW
Citation: Dl. Krah et al., COMBINED USE OF COMPLEMENT AND ANTIIMMUNOGLOBULIN IN AN ENHANCED NEUTRALIZATION ASSAY FOR ANTIBODIES TO VARICELLA-ZOSTER VIRUS, Journal of virological methods, 53(2-3), 1995, pp. 176-187
HISTOLOGIC AND ULTRASTRUCTURAL-CHANGES AFTER LARGE-COLON TORSION, WITH AND WITHOUT USE OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST (WEB-2086), IN PONIES
Authors: WILSON DV PATTERSON JS STICK JA PROVOST PJ
Citation: Dv. Wilson et al., HISTOLOGIC AND ULTRASTRUCTURAL-CHANGES AFTER LARGE-COLON TORSION, WITH AND WITHOUT USE OF A SPECIFIC PLATELET-ACTIVATING-FACTOR ANTAGONIST (WEB-2086), IN PONIES, American journal of veterinary research, 55(5), 1994, pp. 681-688
DEVELOPMENT OF THE FORMALIN-INACTIVATED HEPATITIS-A VACCINE, VAQTA(TM) FROM THE LIVE ATTENUATED VIRUS-STRAIN CR326F
Authors: ARMSTRONG ME GIESA PA DAVIDE JP REDNER F WATERBURY JA RHOAD AE KEYS RD PROVOST PJ LEWIS JA
Citation: Me. Armstrong et al., DEVELOPMENT OF THE FORMALIN-INACTIVATED HEPATITIS-A VACCINE, VAQTA(TM) FROM THE LIVE ATTENUATED VIRUS-STRAIN CR326F, Journal of hepatology, 18, 1993, pp. 190000020-190000026
WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW
Authors: NALIN DR KUTER BJ BROWN L PATTERSON C CALANDRA GB WERZBERGER A SHOUVAL D ELLERBECK E BLOCK SL BISHOP R WIENS B SCHWARTZ SW LEWIS JA SITRIN RD PROVOST PJ MILLER WJ RYAN JL
Citation: Dr. Nalin et al., WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW, Journal of hepatology, 18, 1993, pp. 190000051-190000055
Risultati: 1-8 |